American Century Companies’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-252,234
Closed -$45.4M 1434
2017
Q3
$45.4M Sell
252,234
-157,473
-38% -$21.9M 0.05% 385
2017
Q2
$42.5M Sell
409,707
-74,402
-15% -$6.07M 0.04% 397
2017
Q1
$38M Sell
484,109
-106,234
-18% -$6.57M 0.04% 415
2016
Q4
$26.5M Buy
590,343
+244,172
+71% +$12M 0.03% 475
2016
Q3
$19.3M Buy
346,171
+46,011
+15% +$2.56M 0.02% 547
2016
Q2
$15M Buy
300,160
+16,559
+6% +$814K 0.02% 580
2016
Q1
$13M Sell
283,601
-1,935
-0.7% -$93.7K 0.02% 588
2015
Q4
$17.6M Buy
285,536
+14,270
+5% +$1M 0.02% 526
2015
Q3
$15.1M Buy
271,266
+7,851
+3% +$494K 0.02% 562
2015
Q2
$16.1M Buy
+263,415
New +$15M 0.02% 598

American Century Companies's KITE Position: Q4 2017 in Review

American Century Companies sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 252,234 shares — an estimated $45.4M sold.

American Century Companies first reported a position in KITE in Q2 2015 and held it in 10 quarters. The position peaked at $45.4M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • American Century Companies reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • American Century Companies sold 252,234 Kite Pharma, Inc. shares in Q4 2017, an estimated $45.4M.
  • American Century Companies first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 10 quarters.
  • American Century Companies's Kite Pharma, Inc. position peaked at $45.4M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on American Century Companies's 13F filing for Q4 2017, filed 2 Feb 2018.